Optimizing the Delivery of mRNA to Mesenchymal Stem Cells for Tissue Engineering Applications
Molecular Pharmaceutics · 01.04.2024 · 21 (4) · 1662-1676
DOI: 10.1021/acs.molpharmaceut.3c00898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 20.03.2024. Verfasst von Katie McCormick und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tissue Engineering Research Group, Department of Anatomy and Regenerative Medicine, RCSI, Dublin D02 YN77, Ireland. Hauptthemen laut MEDLINE: Tissue Engineering, Mesenchymal Stem Cells. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science Foundation Ireland, H2020 European Research Council.
Abstract (Originalsprache)
Messenger RNA (mRNA) represents a promising therapeutic tool in the field of tissue engineering for the fast and transient production of growth factors to support new tissue regeneration. However, one of the main challenges to optimizing its use is achieving efficient uptake and delivery to mesenchymal stem cells (MSCs), which have been long reported as difficult-to-transfect. The aim of this study was to systematically screen a range of nonviral vectors to identify optimal transfection conditions for mRNA delivery to MSCs. Furthermore, for the first time, we wanted to directly compare the protein expression profile from three different types of mRNA, namely, unmodified mRNA (uRNA), base-modified mRNA (modRNA), and self-amplifying mRNA (saRNA) in MSCs. A range of polymer- and lipid-based vectors were used to encapsulate mRNA and directly compared in terms of physicochemical properties as well as transfection efficiency and cytotoxicity in MSCs. We found that both lipid- and polymer-based materials were able to successfully condense and encapsulate mRNA into nanosized particles (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tissue Engineering Research Group, Department of Anatomy and Regenerative Medicine, RCSI, Dublin D02 YN77, Ireland.
- Science Foundation Ireland Advance Materials and Bioengineering Research Centre, Dublin D02 W9K7, Ireland.
- , BioNTech SE, Mainz 55131, Germany.
- School of Pharmacy and Biomolecular Sciences, RCSI, Dublin D02 YN77, Ireland.
- Dept. of Chemistry, RCSI, Dublin D02 YN77, Ireland.
- Science Foundation Ireland Centre for Research in Medical Devices, Galway H91 W2TY, Ireland.
ORCID-Profile: Katie McCormick, Heinrich Haas, Andreas Heise, Fergal J O'Brien, Sally-Ann Cryan
Förderung
- Science Foundation Ireland
- H2020 European Research Council
Zitieren
APA
McCormick, K., Moreno Herrero, J., Haas, H., Fattah, S., Heise, A., O'Brien, F. J., & Cryan, S. A. (2024). Optimizing the Delivery of mRNA to Mesenchymal Stem Cells for Tissue Engineering Applications. Molecular Pharmaceutics, 21(4), 1662-1676. https://doi.org/10.1021/acs.molpharmaceut.3c00898
Vancouver
McCormick K, Moreno Herrero J, Haas H, Fattah S, Heise A, O'Brien FJ, et al. Optimizing the Delivery of mRNA to Mesenchymal Stem Cells for Tissue Engineering Applications. Molecular Pharmaceutics. 2024;21(4):1662-1676. doi:10.1021/acs.molpharmaceut.3c00898
BibTeX
@article{McCormick2024,
author = {McCormick, Katie and Moreno Herrero, Jorge and Haas, Heinrich and Fattah, Sarinj and Heise, Andreas and O'Brien, Fergal J and Cryan, Sally-Ann},
title = {Optimizing the Delivery of mRNA to Mesenchymal Stem Cells for Tissue Engineering Applications},
journal = {Molecular Pharmaceutics},
year = {2024},
volume = {21},
number = {4},
pages = {1662--1676},
doi = {10.1021/acs.molpharmaceut.3c00898}
}
EUVIMED